Fundamental view:
The vaccines are coming – we’re saved! Although the arriving vaccines are great for humanity, they are bad for the price of gold. In November, Pfizer and BioNTech announced that their mRNA-based vaccine candidate, BNT162b2, had demonstrated evidence of an efficacy rate above 90% against COVID-19, in the first interim efficacy analysis.
At the start of the week, the data from China showed that the country’s exports in November surged by 21.1% on a yearly basis. With this reading surpassing the market expectation for an increase of 12% by a wide margin, risk flows remained in control of financial markets.
The major economic events deciding the movement of the pair in the next week are Retail Sales monthly report, EIA Crude Oil Stocks Change, Fed Interest Rate Decision at Dec 16, Building Permits, and Initial Jobless Claims at Dec 17 for US.
XAU/USD Weekly outlook: